AU2001294356A1 - Aspartate derivative of amlodipine as calcium channel antagonist - Google Patents

Aspartate derivative of amlodipine as calcium channel antagonist

Info

Publication number
AU2001294356A1
AU2001294356A1 AU2001294356A AU2001294356A AU2001294356A1 AU 2001294356 A1 AU2001294356 A1 AU 2001294356A1 AU 2001294356 A AU2001294356 A AU 2001294356A AU 2001294356 A AU2001294356 A AU 2001294356A AU 2001294356 A1 AU2001294356 A1 AU 2001294356A1
Authority
AU
Australia
Prior art keywords
amlodipine
calcium channel
channel antagonist
aspartate derivative
aspartate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294356A
Inventor
Franciscus Bernardus Gemma Benneker
Jacobus Maria Lemmens
Theodorus Hendricus Antonius Peters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of AU2001294356A1 publication Critical patent/AU2001294356A1/en
Abandoned legal-status Critical Current

Links

AU2001294356A 2000-12-29 2001-08-15 Aspartate derivative of amlodipine as calcium channel antagonist Abandoned AU2001294356A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/258,602 2000-12-29
US09/809,349 2001-03-16

Publications (1)

Publication Number Publication Date
AU2001294356A1 true AU2001294356A1 (en) 2002-07-16

Family

ID=

Similar Documents

Publication Publication Date Title
SI1686119T1 (en) Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
AU2001286233A1 (en) Cement composition
AU2001277621A1 (en) Antiangiogenic bicyclic derivatives
AU2001241128A1 (en) Novel amide compounds
AU2001264256A1 (en) Plaster
AU2002222853A1 (en) Therapeutic compounds
AU2001246883A1 (en) Stabilized pharmaceutical compositions containing calcium channel blockers
AU2001287173A1 (en) Selectively colorable compositions
AU2002222627A1 (en) Tak1 inhibitors
AU2001286750A1 (en) Compositions and methods for exon profiling
GB2372036B (en) Aspartate derivative of amlodipine
AU2002219175A1 (en) Crystalline forms of cerivastatin sodium
AU2001255408A1 (en) Tetrahydro-azepinone derivatives as thrombin inhibitors
AU5029801A (en) Copolymers of allylphosphonium salts
AU2001241037A1 (en) Use of piperidine benzoderivatives as fungicides
AU2001294356A1 (en) Aspartate derivative of amlodipine as calcium channel antagonist
AU2001235764A1 (en) Compositions
EP1215193A3 (en) Production of 2-hydrocarbyl-2-adamantyl acrylate compounds
AU2001269121A1 (en) Substituted amidoalkyl-uracils as parp inhibitors
GB0020183D0 (en) Calcium carbonate compositions
AU2001272388A1 (en) Benzosuberonylpiperidine compounds as analgesics
AU2002237655A1 (en) Substituted benzoindoles as spla2 inhibitors
AU2001279612A1 (en) Substituted polyamine compounds
AU2000236800A1 (en) Novel calcium antagonists
AU2002216038A1 (en) Preparation of monofluoroalkenes